T. Rowe Price Associates’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169M | Sell |
1,789,513
-76,767
| -4% | -$7.26M | 0.02% | 470 |
|
|
2025
Q1 | $118M | Buy |
1,866,280
+32,748
| +2% | +$2.08M | 0.01% | 519 |
|
|
2024
Q4 | $85.2M | Buy |
1,833,532
+498,338
| +37% | +$23.1M | 0.01% | 601 |
|
|
2024
Q3 | $38.4M | Buy |
1,335,194
+385,819
| +41% | +$11.1M | ﹤0.01% | 822 |
|
|
2024
Q2 | $13.7M | Buy |
+949,375
| New | +$13.7M | ﹤0.01% | 1048 |
|